Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis (HERO)

Abbott

Status and phase

Completed

Phase 4

Conditions

Rheumatoid Arthritis

Treatments

Drug: adalimumab

Study type

Interventional

Funder types

Industry

Identifiers

NCT00234897

M04-684

HERO

Details and patient eligibility

About

The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment

Enrollment

1,938 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history.
Subject, based on assessment of investigator, meets the definition of active RA

Exclusion criteria

Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
Female subject who is pregnant or breast-feeding or considering becoming pregnant